eGFR Slope Tracks Kidney Disease in Cardiovascular Trials eGFR Slope Tracks Kidney Disease in Cardiovascular Trials
A new review proposes using the slope of estimated glomerular filtration rate (eGFR) as a surrogate measure of chronic kidney disease progression in cardiovascular outcome trials.Medscape Medical News
Source: Medscape Transplantation Headlines - Category: Transplant Surgery Tags: Nephrology News Source Type: news
More News: Cardiology | Cardiovascular | Chronic Kidney Disease | Heart | Kidney Transplant | Kidney Transplantation | Transplant Surgery | Transplants | Urology & Nephrology